Neuropharmacology is a specialized field that explores the interactions between drugs and the nervous system, delving into pharmacodynamics to understand how drugs exert their effects on the intricate neural networks. This branch of pharmacology investigates the mechanisms by which drugs alter cellular and molecular processes within the nervous system, influencing neurotransmitter systems, receptors, and signal transduction pathways. Pharmacodynamics in neuropharmacology involves studying the drug-receptor interactions, elucidating how drugs modulate neuronal activity, and deciphering the impact on synaptic transmission. Whether enhancing or inhibiting neurotransmitter release, altering receptor sensitivity, or affecting ion channel function, pharmacodynamics plays a pivotal role in shaping the pharmacological responses observed in the nervous system. The study of pharmacodynamics in neuropharmacology extends beyond the individual drug level, examining dose-response relationships, therapeutic indices, and the temporal aspects of drug action. Insights gained from pharmacodynamic studies contribute to the development of more targeted and effective neuropharmaceutical interventions, providing a foundation for advancing treatments in neurological and psychiatric disorders.
The intricate interplay between drugs and the nervous system underscores the importance of pharmacodynamics in shaping therapeutic outcomes. Researchers in neuropharmacology continually strive to unravel these complexities, fostering the development of innovative drugs with enhanced efficacy and reduced adverse effects for various neurological conditions.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand